Remove Community Pharmacies Remove Labelling Remove Medical Records
article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

However, the American Medical Association (AMA) released a statement warning that while most patients benefit from Paxlovid, it is not for everyone. The US FDA has not announced any updates to Lagevrio’s label.

Labelling 111